Search Results

There are 4766 results for: content related to: Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality

  1. Morphological features of TMPRSS2–ERG gene fusion prostate cancer

    The Journal of Pathology

    Volume 212, Issue 1, May 2007, Pages: 91–101, J-M Mosquera, S Perner, F Demichelis, R Kim, MD Hofer, KD Mertz, PL Paris, J Simko, C Collins, TA Bismar, AM Chinnaiyan and MA Rubin

    Article first published online : 23 MAR 2007, DOI: 10.1002/path.2154

  2. Diagnostic and prognostic molecular biomarkers for prostate cancer


    Volume 60, Issue 1, January 2012, Pages: 125–141, Glen Kristiansen

    Article first published online : 23 DEC 2011, DOI: 10.1111/j.1365-2559.2011.04083.x

  3. Combined analysis of TMPRSS2–ERG and TERT for improved prognosis of biochemical recurrence in prostate cancer

    Genes, Chromosomes and Cancer

    Volume 51, Issue 8, August 2012, Pages: 781–791, Rasa Sabaliauskaite, Sonata Jarmalaite, Donatas Petroska, Darius Dasevicius, Arvydas Laurinavicius, Feliksas Jankevicius and Juozas R. Lazutka

    Article first published online : 16 APR 2012, DOI: 10.1002/gcc.21963

  4. Immunohistochemical ETS-related gene detection in a Japanese prostate cancer cohort: Diagnostic use in Japanese prostate cancer patients

    Pathology International

    Volume 61, Issue 7, July 2011, Pages: 409–414, Bungo Furusato, Geert J.H.L. van Leenders, Jan Trapman, Takahiro Kimura, Shin Egawa, Hiroyuki Takahashi, Masakuni Furusato, Tapio Visakorpi and Hiroshi Hano

    Article first published online : 8 JUN 2011, DOI: 10.1111/j.1440-1827.2011.02675.x

  5. In situ sequencing identifies TMPRSS2–ERG fusion transcripts, somatic point mutations and gene expression levels in prostate cancers

    The Journal of Pathology

    Volume 234, Issue 2, October 2014, Pages: 253–261, Sara Kiflemariam, Marco Mignardi, Muhammad Akhtar Ali, Anders Bergh, Mats Nilsson and Tobias Sjöblom

    Article first published online : 4 AUG 2014, DOI: 10.1002/path.4392

  6. TMPRSS2:ERG fusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis



    Article first published online : 8 JUL 2009, DOI: 10.1111/j.1600-0463.2009.02517.x

  7. High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer

    BJU International

    Volume 111, Issue 5, May 2013, Pages: 836–842, Frank P. Smit, Maciej Salagierski, Sander Jannink and Jack A. Schalken

    Article first published online : 12 APR 2013, DOI: 10.1111/bju.12119

  8. Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis

    The Prostate

    Volume 73, Issue 2, January 2013, Pages: 113–120, Grégoire Robert, Sander Jannink, Frank Smit, Tilly Aalders, Daphne Hessels, Ruben Cremers, Peter F. Mulders and Jack A. Schalken

    Article first published online : 5 JUN 2012, DOI: 10.1002/pros.22546

  9. TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients

    The Prostate

    Volume 71, Issue 5, April 2011, Pages: 489–497, Cristina Magi-Galluzzi, Toyonori Tsusuki, Paul Elson, Kelly Simmerman, Chris LaFargue, Raquel Esgueva, Eric Klein, Mark A. Rubin and Ming Zhou

    Article first published online : 28 SEP 2010, DOI: 10.1002/pros.21265

  10. Interrogation of ERG gene rearrangements in prostate cancer identifies a prognostic 10-gene signature with relevant implication to patients' clinical outcome

    BJU International

    Volume 113, Issue 2, February 2014, Pages: 309–319, Tarek A. Bismar, Mohammed Alshalalfa, Lars F. Petersen, Liang Hong Teng, Travis Gerke, Ashraf Bakkar, Amal Al-Mami, Shuhong Liu, Michael Dolph, Lorelei A. Mucci and Reda Alhajj

    Article first published online : 5 SEP 2013, DOI: 10.1111/bju.12262

  11. Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients

    Pathology International

    Volume 62, Issue 11, November 2012, Pages: 742–748, Takahiro Kimura, Bungo Furusato, Jun Miki, Toshihiro Yamamoto, Norihiro Hayashi, Hiroyuki Takahashi, Yuko Kamata, Geert J. H. L. van Leenders, Tapio Visakorpi and Shin Egawa

    Article first published online : 1 NOV 2012, DOI: 10.1111/pin.12006

  12. Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer

    The Journal of Pathology

    Volume 230, Issue 2, June 2013, Pages: 174–183, Christopher Weier, Michael C Haffner, Timothy Mosbruger, David M Esopi, Jessica Hicks, Qizhi Zheng, Helen Fedor, William B Isaacs, Angelo M. De Marzo, William G Nelson and Srinivasan Yegnasubramanian

    Article first published online : 13 MAY 2013, DOI: 10.1002/path.4186

  13. Prevalence and prognostic significance of TMPRSS2-ERG gene fusion in lymph node positive prostate cancers

    The Prostate

    Volume 74, Issue 16, December 2014, Pages: 1647–1654, Achim Fleischmann, Outi R. Saramäki, Inti Zlobec, Diana Rotzer, Vera Genitsch, Roland Seiler, Tapio Visakorpi and George N. Thalmann

    Article first published online : 22 SEP 2014, DOI: 10.1002/pros.22882

  14. PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer

    BJU International

    Volume 107, Issue 3, February 2011, Pages: 477–485, Tarek A. Bismar, Maisa Yoshimoto, Robin T. Vollmer, Qiuli Duan, Matthew Firszt, Jacques Corcos and Jeremy A. Squire

    Article first published online : 29 JUN 2010, DOI: 10.1111/j.1464-410X.2010.09470.x

  15. You have full text access to this OnlineOpen article
    Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth

    Cancer Science

    Volume 105, Issue 10, October 2014, Pages: 1272–1278, Daisuke Obinata, Akiko Ito, Kyoko Fujiwara, Ken-Ichi Takayama, Daisaku Ashikari, Yasutaka Murata, Kenya Yamaguchi, Tomohiko Urano, Tetsuya Fujimura, Noboru Fukuda, Masayoshi Soma, Takayoshi Watanabe, Hiroki Nagase, Satoshi Inoue and Satoru Takahashi

    Article first published online : 17 SEP 2014, DOI: 10.1111/cas.12493

  16. ERG expression in prostate cancer: The prognostic paradox

    The Prostate

    Volume 74, Issue 15, November 2014, Pages: 1481–1487, Michael Taris, Jacques Irani, Pascal Blanchet, Luc Multigner, Xavier Cathelineau and Gaelle Fromont

    Article first published online : 29 AUG 2014, DOI: 10.1002/pros.22863

  17. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity


    Volume 60, Issue 1, January 2012, Pages: 187–198, Christopher E Barbieri, Francesca Demichelis and Mark A Rubin

    Article first published online : 23 DEC 2011, DOI: 10.1111/j.1365-2559.2011.04041.x

  18. TMPRSS2/ERG fusion gene expression alters chemo- and radio-responsiveness in cell culture models of androgen independent prostate cancer

    The Prostate

    Volume 71, Issue 14, 1 October 2011, Pages: 1548–1558, Todd A. Swanson, Sarah A. Krueger, Sandra Galoforo, Bryan J. Thibodeau, Alvaro A. Martinez, George D. Wilson and Brian Marples

    Article first published online : 10 MAR 2011, DOI: 10.1002/pros.21371

  19. Detection of TMPRSS2:ERG fusion gene in circulating prostate cancer cells

    Asian Journal of Andrology

    Volume 10, Issue 3, May 2008, Pages: 467–473, Xueying Mao, Greg Shaw, Sharon Y. James, Patricia Purkis, Sakunthala C. Kudahetti, Theodora Tsigani, Saname Kia, Bryan D. Young, R. Tim D. Oliver, Dan Berney, David M. Prowse and Yong-Jie Lu

    Article first published online : 21 APR 2008, DOI: 10.1111/j.1745-7262.2008.00401.x

  20. Role of dutasteride in pre-clinical ETS fusion-positive prostate cancer models

    The Prostate

    Volume 72, Issue 14, 1 October 2012, Pages: 1542–1549, Bushra Ateeq, Adaikkalam Vellaichamy, Scott A. Tomlins, Rui Wang, Qi Cao, Robert J. Lonigro, Kenneth J. Pienta and Sooryanarayana Varambally

    Article first published online : 13 MAR 2012, DOI: 10.1002/pros.22509